These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 1727374

  • 1. Melphalan penetration of the blood-brain barrier via the neutral amino acid transporter in tumor-bearing brain.
    Cornford EM, Young D, Paxton JW, Finlay GJ, Wilson WR, Pardridge WM.
    Cancer Res; 1992 Jan 01; 52(1):138-43. PubMed ID: 1727374
    [Abstract] [Full Text] [Related]

  • 2. The effect of an amino acid-lowering diet on the rate of melphalan entry into brain and xenotransplanted glioma.
    Groothuis DR, Lippitz BE, Fekete I, Schlageter KE, Molnar P, Colvin OM, Roe CR, Bigner DD, Friedman HS.
    Cancer Res; 1992 Oct 15; 52(20):5590-6. PubMed ID: 1394182
    [Abstract] [Full Text] [Related]

  • 3. Facilitated transport of melphalan at the rat blood-brain barrier by the large neutral amino acid carrier system.
    Greig NH, Momma S, Sweeney DJ, Smith QR, Rapoport SI.
    Cancer Res; 1987 Mar 15; 47(6):1571-6. PubMed ID: 3815357
    [Abstract] [Full Text] [Related]

  • 4. Carrier-mediated delivery of metabotrophic glutamate receptor ligands to the central nervous system: structural tolerance and potential of the L-system amino acid transporter at the blood-brain barrier.
    Reichel A, Begley DJ, Abbott NJ.
    J Cereb Blood Flow Metab; 2000 Jan 15; 20(1):168-74. PubMed ID: 10616805
    [Abstract] [Full Text] [Related]

  • 5. Rapid high-affinity transport of a chemotherapeutic amino acid across the blood-brain barrier.
    Takada Y, Vistica DT, Greig NH, Purdon D, Rapoport SI, Smith QR.
    Cancer Res; 1992 Apr 15; 52(8):2191-6. PubMed ID: 1559223
    [Abstract] [Full Text] [Related]

  • 6. Cationic amino acid transport across the blood-brain barrier is mediated exclusively by system y+.
    O'Kane RL, Viña JR, Simpson I, Zaragozá R, Mokashi A, Hawkins RA.
    Am J Physiol Endocrinol Metab; 2006 Aug 15; 291(2):E412-9. PubMed ID: 16569760
    [Abstract] [Full Text] [Related]

  • 7. Enhancement of transport of D-melphalan analogue by conjugation with L-glutamate across bovine brain microvessel endothelial cell monolayers.
    Sakaeda T, Siahaan TJ, Audus KL, Stella VJ.
    J Drug Target; 2000 Aug 15; 8(3):195-204. PubMed ID: 10938529
    [Abstract] [Full Text] [Related]

  • 8. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
    Du J, Lu WL, Ying X, Liu Y, Du P, Tian W, Men Y, Guo J, Zhang Y, Li RJ, Zhou J, Lou JN, Wang JC, Zhang X, Zhang Q.
    Mol Pharm; 2009 Aug 15; 6(3):905-17. PubMed ID: 19344115
    [Abstract] [Full Text] [Related]

  • 9. Neutral amino acid transport at the human blood-brain barrier.
    Pardridge WM, Choi TB.
    Fed Proc; 1986 Jun 15; 45(7):2073-8. PubMed ID: 3519291
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Large amino acid transporter 1 (LAT1) prodrugs of valproic acid: new prodrug design ideas for central nervous system delivery.
    Peura L, Malmioja K, Laine K, Leppänen J, Gynther M, Isotalo A, Rautio J.
    Mol Pharm; 2011 Oct 03; 8(5):1857-66. PubMed ID: 21770378
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Blood-brain barrier transport of L-tyrosine Conjugates: a model study for the brain targeting using large neutral amino acid transport system.
    Ohnishi T, Maruyama T, Higashi S, Awazu S.
    J Drug Target; 2000 Oct 03; 8(6):395-401. PubMed ID: 11328665
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.